All the latest worldwide HIV and AIDS news, including treatment, prevention, and hepatitis and TB co-infections. News from our own team of writers plus articles we have selected from other sources.

aidsmap hiv & aids news

RSS

← First12345...724Next →

hiv & aids news selected from other sources

  • Pharmaceutical industry
    Glaxo Abandons HIV-Unit Spinoff Plan, Reduces Capital Payout
    Bloomberg | 1 hour ago

    GlaxoSmithKline Plc shares rose as the U.K.’s biggest drug company abandoned plans to spin off its flourishing HIV-drugs unit and reduced funds to be returned to shareholders, retaining capital for bolstering growth. The decision to retain its full stake in ViiV Healthcare, an HIV joint venture with Pfizer Inc., reflects the unit’s “very positive outlook,” Glaxo said.

  • Treatment guidelines
    US guidelines shift to integrase-based combinations for first-line treatment: Atripla relegated due to side effects
    i-Base | 1 hour ago

    The rationale for dropping Atripla is due to concerns about the tolerability of efavirenz, especially the high rate of central nervous system related toxicities. Although this has been a long-standing community concern, DHHS guidelines have consistently recommended efavirenz in previous editions. This tolerability statement is made in the year that efavirenz comes off patent.

  • Immigration
    The hugging immigrant
    BBC World Service (sound file) | 6 hours ago

    An interview with Bisi Alimi, the HIV-positive Nigerian immigrant who has been campaigning against Nigel Farage and UKIP in the seat where Farage is a candidate, South Thanet, and neighbouring areas.

  • New and experimental hepatitis C treatment
    ViiV Healthcare Begins Phase III Programme with dolutegravir/rilpivirine Combination for HIV Maintenance Therapy
    Viiv Healthcare press release | 7 hours ago

    The Phase III programme will evaluate the efficacy, safety, and tolerability of switching to dolutegravir plus rilpivirine from current INI-,NNRTI-, or PI-based antiretroviral regimen in HIV-1-infected adults who are virologically suppressed. In the clinical trials, dolutegravir and rilpivirine will be provided as individual tablets; development of the single-tablet formulation will be concurrent with conduct of the trials.

  • Hepatitis C
    Hepatitis C common among HIV-positive patients in sub-Saharan Africa
    Eurekalert Inf Dis | 8 hours ago

    Around 3% of people in sub-Saharan Africa have been infected with HCV infection, rising to 5.7 per cent in individuals with HIV. The findings will inform the global debate about how treatment should be made available to all those who need it.

  • Behaviour change interventions
    Are scare tactics off the table for public health campaigns targeting HIV?
    Science Daily | 8 hours ago

    Over the last 10 years, public health campaigns in New York City around smoking, obesity, and HIV underwent a dramatic shift to use fear and disgust to spur behavior change, sometimes with the unintended consequence of stigmatizing affected populations. In a new article, scholars explore the implications of this shift to fear-based campaigns in the present public health environment.

  • Promoting HIV testing
    Australia: Men not testing regularly enough for HIV
    Gay News Network | 8 hours ago

    The number of men who have sex with men testing for HIV may be rising, but those who should be testing more often are not doing so.

  • Neurological and cognitive problems
    A New, More Reliable Way to Gauge HIV-Related Cognitive Dysfunction
    AIDSMeds | 8 hours ago

    A new statistical means of assessing HIV-associated neurocognitive dysfunction (HAND) is more reliable than the so-called Frascati and Gisslén methods.

  • Immigration
    Nigerian immigrant who is also HIV positive offers free hugs to public as he urges them not to vote Ukip
    Evening Standard | 9 hours ago

    Bisi Alimi is offering free hugs to anyone who wants to listen to his message in South Thanet, Kent. He has become a regular visitor to the town centre, attracting crowds of people by holding a sign which reads: "I'm an immigrant. Hug me or ask me a question?"

  • The search for a cure
    Researchers “un-can” the HIV virus
    Univesity of Montreal | 05 May 2015

    If the human immunodeficiency virus (HIV) is a bit like a hermetically sealed tin can no one has yet been able to break open, the good news is that researchers at the CHUM Research Centre, affiliated with the University of Montreal, have identified a way to use a “can opener” to force the virus to open up and to expose its vulnerable parts, allowing the immune system cells to then kill the infected cells.

← First12345...1039Next →

Hepatitis C news

WHO recommends global use of newest hepatitis C drugs, urges price reductions.

HIV update

Sign up for HIV update, our fortnightly news bulletin for people living with HIV in the UK.

Treatment as prevention

No-one with an undetectable viral load, gay or heterosexual, transmits HIV in two years of PARTNER study.

aidsmap news apps

Download the free aidsmap news iPhone and android apps.